MedTrace Logo

TCM Syndrome Differentiation of T2DM & MetS

NCT06703684 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 470

Last updated 2026-03-31

No results posted yet for this study

Summary

This study aims to include type 2 diabetes (T2DM) patients comorbid with metabolic syndrome (MetS). The primary aim of the study is to investigate the TCM (Traditional Chinese Medicine) syndrome differentiation of T2DM comorbid with MetS.

Conditions

  • Diabetes Mellitus, Type 2
  • Metabolic Syndrome

Interventions

OTHER

Cross-sectional observational study

This is a cross-sectional observational study. No intervention will be given.

Sponsors & Collaborators

  • Hong Kong Baptist University

    lead OTHER

Principal Investigators

  • Jialing ZHANG, PhD · Hong Kong Baptist University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-20
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06703684 on ClinicalTrials.gov